Recent studies showed that PGD2 has been involved in tumor development via multiple mechanisms, including receptor-mediated response, peroxisome proliferator-activated receptor γ (PPARγ) [10, 14], and reactive oxygen species (ROS) production [15, 16]. The gene discussed is HPGDS; the disease is neoplasm.